D. C. GÜVEN And Ş. YALÇIN, "Neoadjuvant capecitabine in rectal cancer chemoradiotherapy: too early to ring the alarms," INTERNAL MEDICINE JOURNAL , vol.51, no.8, pp.1365-1366, 2021
GÜVEN, D. C. And YALÇIN, Ş. 2021. Neoadjuvant capecitabine in rectal cancer chemoradiotherapy: too early to ring the alarms. INTERNAL MEDICINE JOURNAL , vol.51, no.8 , 1365-1366.
GÜVEN, D. C., & YALÇIN, Ş., (2021). Neoadjuvant capecitabine in rectal cancer chemoradiotherapy: too early to ring the alarms. INTERNAL MEDICINE JOURNAL , vol.51, no.8, 1365-1366.
GÜVEN, DENİZ, And ŞUAYİB YALÇIN. "Neoadjuvant capecitabine in rectal cancer chemoradiotherapy: too early to ring the alarms," INTERNAL MEDICINE JOURNAL , vol.51, no.8, 1365-1366, 2021
GÜVEN, DENİZ C. And YALÇIN, ŞUAYİB. "Neoadjuvant capecitabine in rectal cancer chemoradiotherapy: too early to ring the alarms." INTERNAL MEDICINE JOURNAL , vol.51, no.8, pp.1365-1366, 2021
GÜVEN, D. C. And YALÇIN, Ş. (2021) . "Neoadjuvant capecitabine in rectal cancer chemoradiotherapy: too early to ring the alarms." INTERNAL MEDICINE JOURNAL , vol.51, no.8, pp.1365-1366.
@article{article, author={DENİZ CAN GÜVEN And author={ŞUAYİB YALÇIN}, title={Neoadjuvant capecitabine in rectal cancer chemoradiotherapy: too early to ring the alarms}, journal={INTERNAL MEDICINE JOURNAL}, year=2021, pages={1365-1366} }